E-LIB Suche - Ergebnisse für: Gil-Bazo, I. (Ignacio)

1

Publisher Correction: Anti-TIGIT antibody improves PD-L1 bl..:

Guan, Xiangnan ; Hu, Ruozhen ; Choi, Yoonha...
Nature. 630 (2024) 8016 - p. E9-E9 , 2024

Link: https://doi.org/10.1038/..

2

Publisher Correction: Anti-TIGIT antibody improves PD-L1 bl..:

Guan, Xiangnan ; Hu, Ruozhen ; Choi, Yoonha...
Nature. 627 (2024) 8005 - p. E11-E11 , 2024

Link: https://doi.org/10.1038/..

3

The S-REAL study: Spanish real-world data on unresectable s..:

Gómez Rueda, Ana ; Taus, Álvaro ; Álvarez Álvarez, Rosa...
Clinical and Translational Oncology. 26 (2024) 7 - p. 1779-1789 , 2024

Link: https://doi.org/10.1007/..

4

Trametinib sensitizes KRAS-mutant lung adenocarcinoma tumor..:

Puyalto, Ander ; Rodríguez-Remírez, María ; López, Inés...
Molecular Cancer. 23 (2024) 1 - p. , 2024

Link: https://doi.org/10.1186/..

5

Liquid biopsy for monitoring minimal residual disease in lo..:

Aguilar, Héctor ; López-Roldán, Belén ; Vilalta-Lacarra, Anna...
The Journal of Liquid Biopsy. 4 (2024) - p. 100145 , 2024

Link: https://doi.org/10.1016/..

6

Anti-TIGIT antibody improves PD-L1 blockade through myeloid..:

Guan, Xiangnan ; Hu, Ruozhen ; Choi, Yoonha...
Nature. 627 (2024) 8004 - p. 646-655 , 2024

Link: https://doi.org/10.1038/..

7

Integration of longitudinal deep-radiomics and clinical dat..:

Farina, Benito ; Guerra, Ana Delia Ramos ; Bermejo-Peláez, David...
Journal of Translational Medicine. 21 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

8

Brief report: High incidence of peridiagnosis thromboemboli..:

Aparicio, Inmaculada ; Iranzo, Patricia ; Reyes, Roxana...
Thrombosis Research. 232 (2023) - p. 133-137 , 2023

Link: https://doi.org/10.1016/..

9

A novel [89Zr]-anti-PD-1-PET-CT to assess response to PD-1/..:

Puyalto, Ander ; Rodríguez-Remírez, María ; López, Inés...
Frontiers in Immunology. 14 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

10

MA12.11 A Novel 89Zr-anti-PD1 immunoPET-CT May Predict Resp..:

Puyalto, A. ; Rodríguez-Remírez, M. ; López, I....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S144 , 2023

Link: https://doi.org/10.1016/..

11

P1.06-02 Trametinib Plus ANTI-PD-1 Immunotherapy Impairs Tu..:

Puyalto, A. ; Rodríguez-Remírez, M. ; López, I....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S194 , 2023

Link: https://doi.org/10.1016/..

12

Integration of longitudinal deep-radiomics and clinical dat..:

Farina, B. (Benito) ; Ramos-Guerra, A.D. (Ana Delia) ; Bermejo-Peláez, D. (David)...
info:eu-repo/grantAgreement/AEI/Retos Investigación: Proyectos I+D+i /RTI2018‑098682‑B‑I00 /ES/APRENDIZAJE PROFUNDO ESPACIO-TEMPORAL PARA LA PREDICION DE RESPUESTA DE TRATAMIENTO POR INMUNOTERAPIA (ST-IMMUNO). , 2023

Link: https://hdl.handle.net/1..

13

A novel [89Zr]-anti-PD-1-PET-CT to assess response to PD-1/..:

Puyalto, A. (Ander) ; Rodríguez-Remírez, M. (M.) ; Lopez, I. (Inés)...
https://pubmed.ncbi.nlm.nih.gov/37841258/. , 2023

Link: https://hdl.handle.net/1..

14

Signature-driven repurposing of Midostaurin for combination..:

Macaya, I. (Irati) ; Román, M. (Marta) ; Welch, C. (Connor)...
https://hdl.handle.net/10171/68095. , 2023

Link: https://hdl.handle.net/1..

15

MCLA-129, a human anti-EGFR and anti-c-MET bispecific antib..:

Ou, S.H. ; Moreno Garcia, V. ; Gil Bazo, I....
European Journal of Cancer. 174 (2022) - p. S122 , 2022

Link: https://doi.org/10.1016/..